Senseonics (NYSE:SENS) Shares Down 5.7% – Here’s Why

Senseonics Holdings, Inc. (NYSE:SENS) was down 5.7% during trading on Friday . The stock traded as low as $1.24 and last traded at $1.24. Approximately 5,487,003 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 16,734,430 shares. The stock had previously closed at $1.31.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SENS. StockNews.com assumed coverage on shares of Senseonics in a report on Thursday, December 26th. They set a “sell” rating for the company. HC Wainwright reiterated a “buy” rating and issued a $2.00 price objective on shares of Senseonics in a report on Friday, November 15th.

Senseonics Trading Down 4.2 %

The company has a market capitalization of $747.14 million, a PE ratio of -9.65 and a beta of 0.69. The company has a fifty day simple moving average of $0.69 and a 200-day simple moving average of $0.47. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17.

Insider Activity at Senseonics

In other Senseonics news, CFO Frederick T. Sullivan acquired 124,933 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the completion of the transaction, the chief financial officer now owns 2,478,844 shares of the company’s stock, valued at approximately $941,960.72. The trade was a 5.31 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Timothy T. Goodnow bought 315,000 shares of Senseonics stock in a transaction on Tuesday, December 10th. The stock was acquired at an average price of $0.31 per share, for a total transaction of $97,650.00. Following the transaction, the chief executive officer now directly owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Senseonics

A number of institutional investors and hedge funds have recently made changes to their positions in SENS. Raymond James Financial Inc. acquired a new stake in Senseonics in the 4th quarter valued at approximately $26,000. HighTower Advisors LLC acquired a new stake in shares of Senseonics in the fourth quarter valued at $32,000. FMR LLC raised its holdings in shares of Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares during the period. Ridgecrest Wealth Partners LLC purchased a new stake in shares of Senseonics in the 4th quarter valued at $60,000. Finally, Beck Mack & Oliver LLC acquired a new position in Senseonics during the 4th quarter worth about $79,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.